Manulife (Manufacturers Life Insurance)’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
AWG
CC
VPC
PA
SSC
VCM
VC
AC
Manulife (Manufacturers Life Insurance)'s ANRO Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) opened a new position in Alto Neuroscience (ANRO) in Q1 2026: 23,747 shares worth $534K. The stake represents ﹤0.01% of the portfolio and ranks #2130 among its holdings. This is a return to the name: Manulife (Manufacturers Life Insurance) previously reported a position in ANRO as recently as Q4 2024.
Manulife (Manufacturers Life Insurance) first reported a position in ANRO in Q1 2024 and has held it in 5 quarters since. The position peaked at $753K in Q3 2024. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 23,747 shares of Alto Neuroscience worth $534K as of Q1 2026.
- Alto Neuroscience was a new Manulife (Manufacturers Life Insurance) position in Q1 2026.
- Alto Neuroscience made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2130 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Alto Neuroscience in Q1 2024 and has held it in 5 quarters since.
- Manulife (Manufacturers Life Insurance)'s Alto Neuroscience position peaked at $753K in Q3 2024.
- 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.